Musculoskeletal Oncology

The Musculoskeletal Oncology Service is specialized in treating leg, pelvic and shoulder soft tissue and bone cancers, benign and malignant tumors, bone metastatic cancer, primary bone malignancy, sarcoma, and chronic fractures caused by malignancy in children and adults. Treatment of bone cancer also requires a multidisciplinary approach involving a variety of clinicians such as orthopedic oncologysurgical oncologyradiation oncologyradiology and pathology. Plans for treatment rely on the cancer's size, location, and level. Soft tissue and bone sarcomas are diagnosed and treated successfully by our multidisciplinary sarcoma center. This is the only federally funded and comprehensive sarcoma, where patients in all sarcoma-related disciplines receive integrated care from physicians.

  • Musculoskeletal System
  • Soft Tissue Sarcomas
  • Primary Bone Tumors
  • Physical Therapy
  • Benign Bone Tumors
  • Benign Soft Tissue Tumors (including lipomas, desmoids, cysts, hemangiomas, vascular malformations)
  • Metastatic Bone and Soft Tissue Tumors (including breast, prostate, kidney, lung, thyroid)

Related Conference of Musculoskeletal Oncology

April 18-19, 2024

7th World Congress on Surgeons

Dubai, UAE
September 16-17, 2024

2nd Annual Conference on Surgery

Paris, France
October 22-23, 2024

2nd Global Summit on Geriatrics & Aging

Paris, France

Musculoskeletal Oncology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in